At the time of writing, Aquestive Therapeutics Inc [AQST] stock is trading at $3.99, up 1.27%. An important factor to consider is whether the stock is rising or falling in short-term value. The AQST shares have gain 1.79% over the last week, with a monthly amount glided 8.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on December 17, 2024, and set its price target to $17. On May 10, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $8 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $10 on April 11, 2024. Raymond James initiated its recommendation with a Outperform and recommended $7 as its price target on March 28, 2024. In a note dated April 22, 2019, H.C. Wainwright initiated an Buy rating.
For the past year, the stock price of Aquestive Therapeutics Inc fluctuated between $2.12 and $5.80. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Aquestive Therapeutics Inc [NASDAQ: AQST] shares were valued at $3.99 at the most recent close of the market. An investor can expect a potential return of 75.44% based on the average AQST price forecast.
Analyzing the AQST fundamentals
According to Aquestive Therapeutics Inc [NASDAQ:AQST], the company’s sales were 54.23M for trailing twelve months, which represents an -27.65% plunge. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -1.0%, and Net Profit Margin reading is -1.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is 1.07 and Total Capital is -0.49. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.64.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Aquestive Therapeutics Inc [NASDAQ:AQST] has a current ratio of 4.87. On the other hand, the Quick Ratio is 4.48, and the Cash Ratio is 3.75. Considering the valuation of this stock, the price to sales ratio is 7.31.
Transactions by insiders
Recent insider trading involved Jung Cassie, Chief Operating Officer, that happened on Nov 26 ’24 when 44.0 shares were sold.
